Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04896580 · ClinicalTrials.gov registry record · NA

IIT2020-20-SHIRAZIP-WALK: Nature Walks

A NA study, sponsored by Cedars-Sinai Medical Center.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT04896580 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04896580, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this study is to examine whether nature-based activities provide benefits for breast cancer survivors. The investigators want to know whether a nature-based exercise program is feasible. Women who were diagnosed with breast cancer and have completed cancer treatment will be recruited for the main study. The main study will enroll up to 20 breast cancer subjects in total. This intervention will also include a sub-study examining the same outcomes among adolescents and young adult (AYA) subjects who were diagnosed with cancer (any type) and have completed cancer treatment. The sub-study will enroll up to 20 AYA (ages 18-39) subjects.

Interventions

  • BEHAVIORAL Nature based exercise

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-06-21
Est. Completion 2023-05-18
Phase NA

Sponsor

Cedars-Sinai Medical Center

339 total trials

What the Registry Record Tells You About NCT04896580

The ClinicalTrials.gov registry entry for NCT04896580 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Nature based exercise is the first listed.

NCT04896580 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04896580 about?

NCT04896580 is a clinical study titled "IIT2020-20-SHIRAZIP-WALK: Nature Walks". The purpose of this study is to examine whether nature-based activities provide benefits for breast cancer survivors. The investigators want to know whether a nature-based exercise program is feasible. Women who were diagnosed with breast cancer and have completed cancer treatment will be recruited ...

What is the current status of trial NCT04896580?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-06-21. Estimated completion is 2023-05-18.

What interventions are being tested in trial NCT04896580?

The interventions under investigation include: Nature based exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT04896580?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.